组织蛋白酶B
生物
甲型流感病毒
病毒学
病毒
微生物学
酶
生物化学
作者
Macon D. Coleman,Soon-Duck Ha,S. M. Mansour Haeryfar,Stephen D. Barr,Sung Ouk Kim
出处
期刊:Journal of Virology & Antiviral Research
[OMICS Publishing Group]
日期:2018-01-01
卷期号:07 (01)
被引量:21
标识
DOI:10.4172/2324-8955.1000178
摘要
Influenza A virus (IAV) is the etiologic agent of the febrile respiratory illness, commonly referred to as 'flu'. The lysosomal protease cathepsin B (CTSB) has shown to be involved in the lifecycle of various viruses. Here, we examined the role of CTSB in the IAV lifecycle.CTSB-deficient (CTSB-/-) macrophages and the human lung epithelial cell line A549 cells treated with CA-074Me were infected with the A/Puerto Rico/8/34 strain of IAV (IAV-PR8). Viral entry and propagation were measured through quantitative real-time RT-PCR; production and localization of hemagglutinin (HA) protein in the infected host cells were analysed by Western blots, flow cytometry and confocal microscopy; production of progeny viruses were measured by a hemagglutination assay.CTSB-/- macrophages and CA-074Me-treated A549 cells had no defects in incorporating IAV-PR8 virions and permitting viral RNA synthesis. However, these cells produced significantly lower amounts of HA protein and progeny virions than wild-type or untreated cells.These data indicate that CTSB is involved in the expression of IAV-PR8 HA protein and subsequent optimal production of IAV-PR8 progeny virions. Targeting CTSB can be a novel therapeutic strategy for treating IAV infection.
科研通智能强力驱动
Strongly Powered by AbleSci AI